Quarterly report · Q1
6856.TEDINET S100TFRG
Period2024-01-01 → 2024-03-31
Filed2024-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥70.3bn | 2024-01-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥290.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥65.9bn | 2023-01-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥10.0bn | 2024-01-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥10.4bn | 2023-01-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥10.2bn | 2024-01-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥48.3bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.3bn | 2023-01-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥10.2bn | 2024-01-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥16.4bn | 2023-01-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥7.0bn | 2024-01-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥40.3bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥13.6bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥7.0bn | 2024-01-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥13.6bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥454.1bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥449.0bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥414.1bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥163.9bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥165.3bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥290.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥283.7bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥249.1bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥125.8bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥132.8bn | at 2023-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥166.55 | 2024-01-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥953.71 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥320.99 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥165.69 | 2024-01-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥948.83 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥319.36 | 2023-01-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 63.7% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.0% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.0% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥19.5bn |
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥19.5bn |
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥178m |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥7.6bn |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥7.6bn |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2024-01-01 → 2024-03-31 | −¥316m |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥5.9bn |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥5.9bn |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥348m |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥9.2bn |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥9.2bn |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥2m |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥27.9bn |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥27.9bn |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥9.8bn |
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥15.9bn |
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥15.9bn |
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥330m |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥7.4bn |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥7.4bn |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥43m |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥5.4bn |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥5.4bn |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥529m |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥73m |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥29.0bn |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥29.0bn |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥9.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 389
| Item | Context | Value | Unit |
|---|---|---|---|
| Retained earnings | CurrentQuarterInstant | 221473000000 | JPY |
| Treasury stock | Prior1YearInstant | -1037000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -4091000000 | JPY |
| Shareholders equity | Prior1YearInstant | 253060000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 248159000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 6850000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 9309000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 22785000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 31668000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 312000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 296000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 29947000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 41273000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 706000000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 706000000 | JPY |
| Non controlling interests | Prior1YearInstant | 17000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 19000000 | JPY |
| Net assets | Prior1YearInstant | 283732000000 | JPY |
| Net assets | CurrentQuarterInstant | 290159000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 449030000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 454084000000 | JPY |
| Net sales | Prior1YTDDuration | 65854000000 | JPY |
| Net sales | CurrentYTDDuration | 70252000000 | JPY |
| Cost of sales | Prior1YTDDuration | 36560000000 | JPY |
| Cost of sales | CurrentYTDDuration | 39038000000 | JPY |
| Gross profit | Prior1YTDDuration | 29293000000 | JPY |
| Gross profit | CurrentYTDDuration | 31213000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 18842000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 21203000000 | JPY |
| Operating income | Prior1YTDDuration | 10450000000 | JPY |
| Operating income | CurrentYTDDuration | 10009000000 | JPY |
| Interest income noi | Prior1YTDDuration | 322000000 | JPY |
| Interest income noi | CurrentYTDDuration | 639000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 2000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 1000000 | JPY |
| Subsidy income noi bounty | Prior1YTDDuration | 3000000 | JPY |
| Subsidy income noi bounty | CurrentYTDDuration | 11000000 | JPY |
| Miscellaneous income noi | Prior1YTDDuration | 78000000 | JPY |
| Miscellaneous income noi | CurrentYTDDuration | 60000000 | JPY |
| Non operating income | Prior1YTDDuration | 406000000 | JPY |
| Non operating income | CurrentYTDDuration | 712000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 224000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 212000000 | JPY |
| Foreign exchange losses noe | Prior1YTDDuration | 281000000 | JPY |
| Foreign exchange losses noe | CurrentYTDDuration | 181000000 | JPY |
| Miscellaneous loss noe | Prior1YTDDuration | 31000000 | JPY |
| Miscellaneous loss noe | CurrentYTDDuration | 162000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 537000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 556000000 | JPY |
| Ordinary income | Prior1YTDDuration | 10320000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |